ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
5425 Wisconsin Ave #600, Chevy Chase, MD 20815
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
Home / Education And Resources / Patient Assistance And Reimbursement Guide / Companies / Eisai Inc

EISAI, INC.

Eisai, Inc.

Patient and Reimbursement Assistance

http://www.eisaipatientsupport.com/

Phone Number

1.866.613.4724

Eisai Patient Support offers access and reimbursement support for patients prescribed LENVIMA.

For more information, search LENVIMA in this Guide, go online, or call 1-866-613-4724, Monday through Friday.

Oncology-related products: Lenvima® (lenvatinib) capsules

Eisai Patient Support (EPS)

Eisai Patient Support offers access and reimbursement support, including:

  • Benefits verification
  • Prior authorization information
  • Appeal information
  • Financial assistance program information

For more information on Eisai Patient Support, and to review the terms and conditions, visit www.eisaipatientsupport.com or call 1-866-613-4724.

Co-Pay Card/Out-Of-Pocket Cost Assistance Lenvima

$0 Co-Pay Program

Eligible, commercially insured patients prescribed Lenvima could pay as little as $0 out of pocket for each prescription. Eisai will pay up to $10,000 per year to assist with the out-ofpocket costs for Lenvima. Depending on the insurance plan, a patient could have additional financial responsibility for any amounts over Eisai's maximum liability. Commercial insurance required. This program is not available to patients enrolled in state or federal healthcare programs, including Medicare, Medicaid, Medigap, VA, DoD, or TRICARE.

For questions about the program, call 1-855-347-2448 or visit www.eisaipatientsupport.com/lenvima for full terms and conditions.

Patient Assistance Program

Lenvima Patient Assistance Program

The Lenvima Patient Assistance Program is for patients who need help paying for Lenvima. This program provides Lenvima at no cost to uninsured and financially burdened patients who meet the program eligibility criteria.

Complete the Lenvima Eisai Patient Support Enrollment Form and fax it to Eisa Patient Support at 1-855-246-5192.

Health care professionals can also enroll patients by sending an electronic prescription for Lenvima directly to Eisai Patient Support Pharmacy.

Note: A patient's signature is required to complete enrollment. Patients can sign the form electronically online.

Dose Exchange Program

Lenvima Dose Exchange Program

There may be times when a healthcare provider needs to dose reduce a patient during the course of Lenvima treatment due to an adverse reaction before the patient has finished their current supply. Through the Lenvima Dose Exchange Program, eligible patients who require a dose reduction can exchange up to 15 unused doses for the same number of doses at the reduced dose strength at no additional cost.

The program allows patients to exchange unused 20-mg doses for 14-mg doses and 10-mg doses to 8mg doses when a healthcare provider has directed a dose reduction based on the prescribing information.

Complete the Lenvima Dose Exchange Enrollment Form and fax it to Eisai Patient Support at 1-855-246-5192.

Temporary Supply Program

Lenvima Temporary Supply Program

Through the LENVIMA Temporary Supply Program, eligible patients may receive up to a 30day supply of LENVIMA (dispensed in up to three 10-day increments) while awaiting a coverage determination from their insurance provider.

Complete the LENVIMA Temporary Supply Program Enrollment Form and fax to 1-855246-5192.

Co-Pay Card/Out-Of-Pocket Cost Assistance

Halaven $0 Co-Pay Program

Eligible, commercially insured patients could pay as little as $0 out of pocket for each prescription. Eisai will pay up to $18,000 per year to assist with the out-of-pocket costs for Halaven. Depending on the insurance plan, a patient could have additional financial responsibility for any amounts over Eisai’s maximum liability.

To enroll, fax the completed enrollment form to 1-844-745-2350.

For questions about the program and full terms and conditions, visit https://www.halaven.com/hcp/metastatic-breast-cancer/patient-assistance.